Tate & Lyle PLC (LON:BD15) has been given an average rating of “Hold” by the nine ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 685.56 ($9.47).
BD15 has been the subject of a number of analyst reports. Societe Generale set a GBX 680 ($9.39) price target on Tate & Lyle and gave the stock a “buy” rating in a research note on Friday, February 9th. Jefferies Group set a GBX 750 ($10.36) price target on Tate & Lyle and gave the stock a “buy” rating in a research note on Monday, October 23rd. Kepler Capital Markets set a GBX 630 ($8.70) price objective on shares of Tate & Lyle and gave the company a “buy” rating in a report on Wednesday. Deutsche Bank set a GBX 650 ($8.98) price objective on shares of Tate & Lyle and gave the company a “neutral” rating in a report on Monday. Finally, Berenberg Bank set a GBX 655 ($9.05) price objective on shares of Tate & Lyle and gave the company a “neutral” rating in a report on Friday, February 9th.
Shares of Tate & Lyle (LON:BD15) opened at GBX 111.50 ($1.54) on Wednesday. Tate & Lyle has a 12 month low of GBX 102 ($1.41) and a 12 month high of GBX 116 ($1.60). The stock has a market capitalization of $2,660.00 and a price-to-earnings ratio of 210.38.
About Tate & Lyle
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.